NCM Capital Management LLC Purchases 7,276 Shares of CVS Health Co. (NYSE:CVS)

NCM Capital Management LLC lifted its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 184.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,225 shares of the pharmacy operator's stock after purchasing an additional 7,276 shares during the period. NCM Capital Management LLC's holdings in CVS Health were worth $504,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. Whitebox Advisors LLC purchased a new position in shares of CVS Health in the fourth quarter worth approximately $249,000. B&D White Capital Company LLC purchased a new position in shares of CVS Health in the fourth quarter worth approximately $417,000. Fairfax Financial Holdings Ltd. Can purchased a new position in shares of CVS Health in the fourth quarter worth approximately $121,742,000. Lazard Asset Management LLC increased its position in shares of CVS Health by 7.3% in the fourth quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator's stock worth $192,617,000 after acquiring an additional 293,406 shares in the last quarter. Finally, Seizert Capital Partners LLC grew its position in CVS Health by 22.8% during the fourth quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock valued at $25,566,000 after purchasing an additional 105,708 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on CVS shares. Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Leerink Partners raised shares of CVS Health from a "market perform" rating to an "outperform" rating and boosted their price objective for the company from $55.00 to $75.00 in a research report on Thursday, February 13th. Royal Bank of Canada boosted their price objective on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research report on Monday, May 5th. Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Finally, Robert W. Baird lifted their target price on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, CVS Health has an average rating of "Moderate Buy" and a consensus target price of $74.94.

Insider Activity at CVS Health

In related news, SVP James David Clark sold 7,513 shares of the company's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This represents a 47.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.22% of the company's stock.

CVS Health Stock Performance

Shares of NYSE CVS traded up $0.58 during trading hours on Friday, hitting $60.80. 8,141,495 shares of the stock were exchanged, compared to its average volume of 11,331,035. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The company's 50 day moving average is $66.15 and its 200 day moving average is $59.41. The firm has a market capitalization of $76.91 billion, a P/E ratio of 16.61, a P/E/G ratio of 0.98 and a beta of 0.60. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business's quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.31 EPS. On average, research analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.38%. The ex-dividend date was Tuesday, April 22nd. CVS Health's payout ratio is currently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.